Sawalha, Y., Hu, M., Welkie, R., Shoemaker, A., Choi, Y., Sigmund, A., Voorhees, T., Bond, D., Reneau, J., Alinari, L., Brammer, J., Christian, B., Baiocchi, R., Bachanova, V., Maddocks, K. (2025). Phase IB/II trial of epcoritamab plus ibrutinib in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood-2025-8239